OTCMKTS:PARNF

Parnell Pharmaceuticals Stock Forecast, Price & News

$0.10

+0.02 (+25.00 %)

(As of 09/17/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.10

▼

$0.10

50-Day Range

$0.04

▼

$0.27

52-Week Range

$0.04

▼

$0.89

Volume177 shs

Average Volume4,103 shs

Market Capitalization$2 million

P/E RatioN/A

Dividend YieldN/A

Beta5.14

30 days | 90 days | 365 days | Advanced Chart

Receive PARNF News and Ratings via Email

Sign-up to receive the latest news and ratings for Parnell Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

About Parnell Pharmaceuticals

Parnell Pharmaceuticals Holdings Ltd. operates as a veterinary pharmaceutical company. The firm engages in the development, manufacture and commercializing animal health solutions. It operates through the following segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. The Companion Animal segment sells osteoarthritis suite of products Zydax, Glyde and Tergive for canine and equine species. The Production Animal-U.S. segment includes reproductive hormone portfolio across production animals. The Production Animal-Rest of World segment provides reproductive hormone products outside of the U.S. The Manufacturing Operations segment involves in sterile manufacturing and release of pharmaceutical products. The company was founded on June 25, 2009 and is headquartered in Sydney, Australia.

Parnell Pharmaceuticals (OTCMKTS:PARNF) Trading Up 212.4%
September 14, 2021 | americanbankingnews.com

Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
July 14, 2021 | finance.yahoo.com

DW Healthcare Partners Invests in Parnell
April 12, 2021 | finance.yahoo.com

Parnell Pharmaceuticals Holdings: Notice of Annual General Meeting and Explanatory Memorandum
January 22, 2021 | finanznachrichten.de

Notice of Annual General Meeting and Explanatory Memorandum
January 22, 2021 | finance.yahoo.com

News for Parnell Pharmaceuticals Holdings Ltd
December 30, 2020 | markets.businessinsider.com

Results of General Meeting of Shareholders Held December 17, 2020
December 21, 2020 | finance.yahoo.com

DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
December 21, 2020 | finance.yahoo.com

Parnell Pharmaceuticals Holdings Ltd (PARNF)
November 5, 2020 | nasdaq.com

Parnell Pharmaceuticals Holdings Ltd.
June 17, 2020 | www.marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PARNF
Previous SymbolNASDAQ:PARN
CUSIPN/A
CIKN/A
Webwww.parnell.com
Phone(129) 667-4411
Employees78
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares20,000,000
Market Cap$2 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Parnell Pharmaceuticals.

4.7 Community Rank

Outperform Votes
Parnell Pharmaceuticals has received 109 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Parnell Pharmaceuticals has received 47 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Parnell Pharmaceuticals has received 69.87% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Parnell Pharmaceuticals and other stocks. Vote “Outperform” if you believe PARNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PARNF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Parnell Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Parnell Pharmaceuticals does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Parnell Pharmaceuticals insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.01% of the stock of Parnell Pharmaceuticals is held by institutions.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Parnell Pharmaceuticals (OTCMKTS:PARNF) Frequently Asked Questions

What stocks does MarketBeat like better than Parnell Pharmaceuticals?

Wall Street analysts have given Parnell Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Parnell Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Parnell Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Parnell Pharmaceuticals' stock was trading at $0.1001 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PARNF stock has decreased by 0.1% and is now trading at $0.10.
View which stocks have been most impacted by COVID-19.

Who are Parnell Pharmaceuticals' key executives?

Parnell Pharmaceuticals' management team includes the following people:

Brad R. McCarthy, CEO, CFO, Secretary & Executive Director
Leonardo Avendano, Vice President-Manufacturing
Lee Whaley, Vice President-Regulatory

Who are some of Parnell Pharmaceuticals' key competitors?

Some companies that are related to Parnell Pharmaceuticals include Helix BioMedix (HXBM), ULURU (ULUR), BriaCell Therapeutics (BCTXF), Intellipharmaceutics International (IPCIF), Vicapsys Life Sciences (VICP), SciSparc (SPRCY), Nexien BioPharma (NXEN), Amarantus BioScience (AMBS), International Stem Cell (ISCO), Akorn (AKRXQ), Kaya (KAYS), Kaya (KAYS), Adhera Therapeutics (ATRX), ImmunoCellular Therapeutics (IMUC) and ImmunoCellular Therapeutics (IMUCD).
View all of PARNF's competitors.

What is Parnell Pharmaceuticals' stock symbol?

Parnell Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARNF."

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Parnell Pharmaceuticals' stock price today?

One share of PARNF stock can currently be purchased for approximately $0.10.

How much money does Parnell Pharmaceuticals make?

Parnell Pharmaceuticals has a market capitalization of $2 million.

How many employees does Parnell Pharmaceuticals have?

Parnell Pharmaceuticals employs 78 workers across the globe.

What is Parnell Pharmaceuticals' official website?

The official website for Parnell Pharmaceuticals is www.parnell.com.

Where are Parnell Pharmaceuticals' headquarters?

Parnell Pharmaceuticals is headquartered at UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015.

How can I contact Parnell Pharmaceuticals?

Parnell Pharmaceuticals' mailing address is UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015. The company can be reached via phone at (129) 667-4411 or via email at [email protected].

This page was last updated on 9/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Parnell Pharmaceuticals Stock Forecast, Price & News

About Parnell Pharmaceuticals

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment